You have 9 free searches left this month | to do more

cedazuridine

Cedazuridine is a drug used to treat Acute Myeloid Leukemia, Chronic Myelocytic Leukemia, Healthy Volunteers, and other conditions. Cedazuridine is being actively studied in 3 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
Astex Pharmaceuticals, Inc.John Theurer Cancer Center / Hackensack University
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsMD Anderson Cancer Center
TakedaPRA Health Sciences
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Thorough QT Assessment of Cedazuridine in Healthy Subjects
Recruiting
  • Healthy Volunteers
  • Cedazuridine
  • +2 more
  • Groningen, Netherlands
    PRA Health Sciences
2021-08-03
Aug 3, 2021
T
A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic Syndromes
Withdrawn
  • Myelodysplastic Syndromes (MDS)
  • (no location specified)
2021-09-23
Sep 23, 2021
S
Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors
Recruiting
  • Solid Tumor
  • Los Angeles, California
  • +1 more
2021-11-18
Nov 18, 2021
A
A Study of ASTX030 (Cedazuridine in Combination With Azacitidine) in MDS, CMML, or AML
Recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Hackensack, New Jersey
  • +4 more
2022-01-24
Jan 24, 2022